\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes Climate, Energy, Mobility MissionsThe research & innovation actions supporting the implementation of the Mission on Climate-neutral and Smart Cities 'HORIZON-MISS-CIT-2021-02’ closed on 26 April 2022.
For the above mentioned call 37 proposals were submitted.
The breakdown per topic:
HORIZON-MISS-2021-CIT-02-01 (IA): 9 proposals
HORIZON-MISS-2021-CIT-02-02 (IA): 5 proposals
HORIZON-MISS-2021-CIT-02-03 (FPA): 2 proposals
HORIZON-MISS-2021-CIT-02-04 (IA): 6 proposals
HORIZON-MISS-2021-CIT-02-05 (CSA): 15 proposals
Source: Funding and Tender Portal
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
